(2 H, q, J 7.5, CH2), 3.47 (1 H, s, OH ), 2.98 (1 H, s, OH ), 1.32
(3 H, t, J 7.5, CH3); δC (100 MHz, CDCl3) 173.2, 133.3, 130.2,
129.7, 123.5, 87.6, 77.6, 75.2, 65.9, 64.0, 15.6; m/z (EI) 234 (3%,
Mϩ), 143 (9), 131 (100, C9H7Oϩ), 115 (35), 104 (89), 76 (63).
HRMS (FABϩLR, C13H14O4). Calc. 234.0892, found. 234.0897.
(2S*,3S*)-2,3-Dihydroxycyclohexanone (36).5 Following the
general procedure diol 36 (179 mg, 1.38 mmol, 69%) was
obtained as a colourless solid; mp 52 ЊC; Rf 0.25 (3 : 2 pentane/
ethyl acetate); νmax(KBr)/cmϪ1 3405 (s), 2949 (m), 1718 (s), 1140
(m), 1107 (m) 1075 (m); δH (400 MHz, CDCl3) 4.35–4.39 (1 H,
m, H-2), 4.13 (1 H, dd, J 3.3, 1.2, H-3), 3.49 (2 H, s, OH ), 2.49
(1 H, dq, J 13.6, 2.3, CH2), 2.32 (1 H, dt, J 13.6, 1.2, CH2), 2.03–
2.14 (2 H, m, CH2), 1.75–1.82 (2 H, m, CH2); δC (100 MHz,
CDCl3) 210.2, 77.5, 72.8, 39.1, 29.0, 21.2; m/z (EI) 130 (37%,
Mϩ), 112 (61), 86 (79), 83 (76), 73 (80), 69 (55), 58 (67), 57 (92),
55 (100, C3H3Oϩ).
Benzoic acid 1-(1,2-dihydroxy-2-phenyl-ethyl)-3-phenyl-prop-
2-ynyl ester (27). Following the general procedure diol 27 was
obtained as a diastereomeric mixture (syn-27/anti-27, 1.4 : 1.0
(1H NMR-integration)) as a colourless oil (395 mg, 1.06 mmol,
53%), that was separated via flash-chromatography.
Diastereomer 1: (1S*,2R*,3R*)-benzoic acid (1,2-dihydroxy-
2-phenyl-ethyl)-3-phenyl-prop-2-ynyl ester (anti-27). (164 mg,
0.44 mmol, 22%); (found: C, 77.38; H, 5.38. C24H20O4 requires:
C, 77.40; H, 5.41%); Rf 0.21 (3 : 1 pentane/ethyl acetate);
νmax(film)/cmϪ1 3421 (s), 3063 (m), 3033 (m), 2927 (m), 1726 (s),
1601 (m), 1491 (m), 1452 (m), 1267 (s), 1112 (m), 1069 (m), 1026
(m); δH (400 MHz, CDCl3) 7.97 (2 H, d, J 8.0, aryl-H ), 7.62–
7.16 (13 H, m, aryl-H ), 5.87 (1 H, d, J 5.5, H-3), 5.11 (1 H, d,
J 4.8, H-1), 4.13 (1 H, dd, J 5.1, 5.1, H-2), 3.26 (2 H, s, OH );
δC (100 MHz, CDCl3) 165.6, 140.5, 133.5, 132.1, 130.0, 129.1,
128.8, 128.5,128.4, 128.3, 126.8, 121.8, 87.7, 83.8, 77.0, 73.7,
66.2.
Diastereomer 2: (1R*,2S*,3R*)-benzoic acid (1,2-dihydroxy-
2-phenyl-ethyl)-3-phenyl-prop-2-ynyl ester (syn-27). (231 mg,
0.62 mmol, 31%); (found: C, 77.41; H, 5.40. C24H20O4 requires:
C, 77.40; H, 5.41%); νmax(film)/cmϪ1 3409 (s), 3063 (m), 2033
(m), 2928 (m), 1732 (s), 1601 (m), 1491 (m), 1452 (m), 1266 (s),
1107 (m), 1069 (m), 1026 (m); δH (400 MHz, CDCl3) 8.04 (2 H,
d, J 7.6, aryl-H ), 7.64–7.15 (13 H, m, aryl-H ), 5.70 (1 H, d,
J 4.1, H-3), 4.93 (1 H, d, J 6.1, H-1), 4.14 (1 H, dd, J 6.1, 4.1,
H-2), 3.28 (2 H, s, OH ); δC (100 MHz, CDCl3) 165.4, 139.7,
133.6, 132.2, 130.0, 129.4, 129.2, 128.9, 128.6, 128.6, 128.4,
126.9, 121.8, 88.3, 82.9, 76.7, 74.2, 66.5.
(3S*,4S*)-3,4-Dihydroxychroman-2-one (37). Following the
general procedure diol 37 (285 mg, 1.58 mmol, 79%) was
obtained as a colourless solid; (found: C, 59.97; H, 4.52.
C9H8O4 requires: C, 60.00; H, 4.48%); mp 142 ЊC; Rf 0.58 (1 : 1
pentane/ethyl acetate); νmax(KBr)/cmϪ1 3431 (s), 3308 (s), 2887
(w), 1774 (s), 1487 (m), 1461 (s), 1158 (s), 1129 (s), 1113 (s),
1066 (s); δH (400 MHz, (CD3)2CO) 7.45–7.39 (2 H, m, aryl-H ),
7.20 (1 H, t, J 7.5, aryl-H ), 7.07 (1 H, d, J 8.1, aryl-H), 4.92–
4.87 (2 H, m, OH ), 4.79 (1 H, d, J 6.0, H-3), 4.69 (1 H, dd, J 6.0,
3.4, H-2); δC (100 MHz, (CD3)2CO) 170.1, 152.0, 131.2, 130.3,
125.3, 117.3, 71.6, 70.1; m/z (EI) 180 (15%, Mϩ), 123 (100,
C7H7O2ϩ), 105 (25), 95 (29), 77 (46); HRMS (FABϩLR,
C9H8NaO4). Calc. 203.0320, found. 203.0349.
(1S*,2S*,3S*)-2,3-Dihydroxycyclohexyl acetate (anti-39).5
Following the general procedure diol 39 was obtained as a
diastereomeric mixture (syn-39/anti-39, 1.0 : 32.3 (1H NMR-
integration)) as a colourless oil (254 mg, 1.46 mmol, 73%), that
was separated via flash-chromatography (3 : 2 pentane/ethyl
acetate).
Diastereomer 1: (1S*,2S*,3S*)-2,3-dihydroxycyclohexyl acet-
ate (anti-39). (246 mg, 1.41 mmol, 71%); Rf 0.19 (3 : 2 pentane/
ethyl acetate); νmax(film)/cmϪ1 3442 (s), 2942 (w), 2870 (w), 1732
(s), 1066 (m), 1042 (m); δH (400 MHz, CDCl3) 4.95 (1 H, ddd,
J 9.7, 4.3, H-1), 4.03 (1 H, ddd, J 4.3, 2.8, H-2), 3.52 (1 H, dd,
J 8.5, 3.0, H-3), 3.30 (2 H, s, OH ), 2.01 (3 H, s, CH3), 1.88–1.94
(1 H, m, H-6), 1.78–1.85 (1 H, m, H-4), 1.62–1.71 (1 H, m, H-5),
1.45–1.51 (1 H, m, H-5), 1.38–1.44 (1 H, m, H-4), 1.26–1.36
(1 H, m, H-6); δC (100 MHz, CDCl3) 172.0, 77.1, 74.4, 70.1,
30.1, 29.2, 21.5, 18.3; m/z (EI) 114 (48%, Mϩ-CH4O2), 96 (50),
70 (100, C4H6Oϩ), 57 (74).
Diastereomer 2: (1S*,2R*,3R*)-2,3-dihydroxycyclohexyl
acetate (syn-39). (8 mg, 0.05 mmol, 2%); Rf 0.09 (3 : 2 pentane/
ethyl acetate); νmax(film)/cmϪ1 3442 (s), 2942 (w), 2870 (w), 1732
(s), 1066 (m), 1042 (m); δH (400 MHz, CDCl3) 4.70 (1 H, ddd,
J 10.5, 4.8, 2.5, H-1), 4.02 (1 H, s, H-2), 3.60 (1 H, ddd, J 10.3,
4.8, 2.8, H-3), 2.88 (2 H, s, OH ), 2.02 (3 H, s, CH3), 1.55–1.74 (4
H, m, CH2), 1.15–1.28 (2 H, m, CH2); δC (100 MHz, CDCl3)
170.6, 74.0, 71.3, 70.8, 28.1, 24.6, 21.6, 19.5; m/z (EI) 114 (68%,
Mϩ Ϫ CH4O2), 96 (42), 70 (100, C4H6Oϩ), 57 (44).
(1S*,2R*)-1-Methyl-cyclopentane-1,2-diol (33).25 Following
the general procedure diol 33 (142 mg, 1.22 mmol, 61%) was
obtained as a colourless solid; mp 23 ЊC; Rf 0.17 (3 : 1 pentane/
ethyl acetate); νmax(KBr)/cmϪ1 3454 (s), 3394 (s), 3307 (s), 2970
(s), 2869 (m), 1465 (m), 1414 (m), 1373 (m), 1339 (m), 1165 (s),
1145 (s), 1122 (s); δH (400 MHz, CDCl3) 3.56 (1 H, dd, J 7.0,
H-2), 2.10 (2 H, s, OH ), 1.97–1.89 (1 H, m, CH2), 1.88 (3 H, m,
CH2), 1.62–1.46 (2 H, m, CH2), 1.29 (3 H, s, CH3); δC (100
MHz, CDCl3) 87.1, 86.3, 37.2, 30.0, 25.9, 19.4; m/z (EI) 115
(23%, Mϩ Ϫ H), 98 (100, Mϩ Ϫ H2O), 82 (68), 67 (81), 55 (35).
(1S*,2S*)-Indane-1,2-diol (34).26 Following the general pro-
cedure diol 34 (225 mg, 1.50 mmol, 75%) was obtained as a
colourless solid; mp 107 ЊC; Rf 0.32 (5 : 1 pentane/ethyl acetate);
νmax(KBr)/cmϪ1 3523 (m), 3440 (s), 3334 (s, br), 2951 (w), 2924
(m), 1579 (w), 1460 (w), 1431 (w), 1319 (s), 1153 (s), 1105 (s);
δH (400 MHz, CDCl3) 7.41–7.93 (1 H, m, aryl-H ), 7.26–7.09 (3
H, m, aryl-H ), 4.97 (1 H, d, J 5.0, H-1), 4.46 (1 H, dd, J 9.0, 5.0,
H-2), 3.08 (1 H, dd, J 16.3, 5.8, H-3), 2.92 (1 H, dd, J 16.3, 3.5,
H-3), 2.65 (2 H, s, OH ); δC (100 MHz, CDCl3) 142.1, 140.3,
129.0, 127.4, 125.6, 125.2, 76.1, 73.6, 38.8; m/z (EI) 146 (73%,
Mϩ Ϫ 2 H2), 107 (83), 91 (62), 79 (81), 69 (59), 60 (100,
C2H4O2ϩ).
3,4-Dihydroxy-cyclohexanecarbonitrile (41). Following the
general procedure diol 41 was obtained as an inseparable
diastereomeric mixture (syn-41/anti-41, 1.0 : 3.3 (1H NMR-
integration)) as a colourless oil (254 mg, 1.46 mmol, 73%);
(found: C, 59.52; H, 7.86. C7H11NO2 requires: C, 59.56; H,
7.85%); Rf 0.18 (diethyl ether); νmax(KBr)/cmϪ1 3447 (s), 2954
(m), 2246 (m), 1635 (m), 1073 (m).
Diastereomer 1: (1R*,3S*,4R*)-3,4-dihydroxy-cyclohexane-
carbonitrile (anti-41). δH (400 MHz, CDCl3) 4.05 (1 H, m, H-1),
3.78 (1 H, m, H-3), 2.92 (1 H, m, H-4), 2.12–2.19 (1 H, m, CH2),
2.05 (2 H, s, OH ), 1.91–1.98 (1 H, m, CH2), 1.73–1.81 (3 H, m,
CH2), 1.57–1.62 (1 H, m, CH2); δC (100 MHz, CDCl3) 122.3,
69.5, 67.9, 32.8, 31.4, 27.2; m/z (EI) 140 (2%, Mϩ Ϫ H), 114
(17), 96 (35), 85 (84), 69 (100, C5H9ϩ), 54 (88).
(1S*,2R*)-1-Methyl-cyclohexane-1,2-diol (35).27 Following
the general procedure diol 35 (195 mg, 1.58 mmol, 79%) was
obtained as a colourless solid; mp 67 ЊC; Rf 0.78 (3 : 1 pentane/
ethyl acetate); νmax(KBr)/cmϪ1 3326 (s), 2991 (m), 2938 (s), 2881
(s), 2860 (s), 1716 (m), 1458 (m), 1444 (m), 1405 (m), 1370 (m),
1151 (s), 1087 (s), 1063 (s); δH (400 MHz, CDCl3) 3.27 (1 H, t,
J 5.7, H-2), 2.34 (2 H, s, OH ), 1.79–1.72 (1 H, m, CH2), 1.68–
1.54 (5 H, m, CH2), 1.41–1.30 (2 H, m, CH2), 1.22 (3 H, s, CH3);
δC (100 MHz, CDCl3) 82.5, 72.2, 37.2, 37.0, 29.0, 22.0; m/z (EI)
129 (15%, Mϩ Ϫ H), 112 (100, Mϩ Ϫ H2O), 96 (97), 81 (91), 71
(44), 55 (36).
Diastereomer 2: (1S*,3S*,4R*)-3,4-dihydroxy-cyclohexane-
carbonitrile (syn-41). (164 mg, 0.44 mmol, 22%); δH (400 MHz,
CDCl3) 3.91 (1 H, m, H-3), 3.65 (1 H, m, H-4), 2.52 (1 H, m,
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2, 1 1 1 6 – 1 1 2 4
1123